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ScienceDirectSignalling circuits based on quorum sensing mechanisms
have been popular tools for synthetic biology. Recent
advances in our understanding of the analogous systems
regulating antibiotics production in soil bacteria suggest that
these might provide useful complementary tools to increase
the complexity of possible circuit designs. Here we discuss
the diversity of these natural circuits, which use g-
butyrolactones (GBLs) as their main inter-cellular signal,
highlighting the range of new building blocks they could
provide, as well as a number of exciting recent applications of
GBL-based circuits in heterologous systems. We conclude by
presenting examples of the novel circuit complexity that
could become accessible through the use of GBL-based
designs.
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Introduction
Synthetic biology aims at the rational design of biological
systems with novel functionalities by using approaches
from engineering, such as modularity [1], orthogonality
[2] and computer-aided modelling [3] and design [4]. One
major challenge of synthetic biology is to develop new
regulatory circuits that allow the tight and composable
control of gene expression over a wide range of conditions.
One popular circuit design exploits the machinery of
quorum sensing inspired by the microorganism Vibrio
fischeri, which is capable of emitting light as a response
to increasing cell density, communicated through an
acyl homoserine lactone (AHL) signal [5]. In synthetic
biology, circuits based on this quorum sensing mechanism
have been used to generate a wide diversity of heterolo-
gous expression systems, for example, synchronous oscil-
lators [6]; noise-free genetic logic gates [7,8]; biological
devices that mimic analogue computing [9]; programmedwww.sciencedirect.com population control [10]; and sender–receiver systems,
where a sender strain produces the quorum signal and a
receiver strain constitutively expresses the corresponding
receptor, which were used by Basu et al. to perform
programmed synthetic pattern formation in Escherichia coli
[11].
At the core of the V. fischeri circuit are the signalling
molecule, AHL, and two regulatory proteins, LuxI, a
synthase responsible of the production of AHL [12], and
the AHL receptor, the repressor LuxR, a pleiotropic
regulator from the TetR family of DNA-binding pro-
teins. Together these control the expression of the
downstream genes of the lux cluster (luxCDABEG),
which encode the machinery for bioluminescence
[13]. The AHL signalling molecule binds to the LuxR,
forming the LuxR–AHL complex. In turn, the LuxR–
AHL complex binds to the lux box, which not only
activates transcription of the bioluminescence biosyn-
thesis lux gene cluster, but also increases transcription of
the luxR and luxI, leading to the synthesis of more AHL.
This generates a positive feedback loop resulting in a
switch-like transition to the light-emitting state [14,15].
This transition is known as a bistable switch and is
characterized by the presence of two stable states
(OFF and ON) and a transient or unstable intermediate
state [16]. Bistability is often observed in combination
with hysteresis: the amount of input (i.e. signalling
molecule concentration) to undergo the OFF to ON
transition is different from the one required to undergo
the ON to OFF transition. Hysteretic bistability has
the important advantage that it prevents fluctuating
responses of the system close to the threshold concen-
tration [17].
However, despite the diverse range of exciting applica-
tions, AHL-based circuits have a couple of limitations.
Most of the reported devices use the same AHL signal-
ling molecule (3-oxo-C6-HL) as input and the same
receptor (LuxR) as the sensor, limiting the composition
of more complex circuits. Furthermore, evidence sug-
gests that different autoinducers can be promiscuous,
resulting in signal crosstalk between two different sys-
tems [18], and that the use of AHL-based circuits in
mammalian cells may be limited, as these contain de-
fence mechanisms to degrade AHLs [19] and may alter
their behaviour and development in the presence of these
molecules [20], resulting in a loss of orthogonality of the
device.
In this review we discuss recent work that opens the
possibility of expanding the toolbox of quorum-sensingCurrent Opinion in Chemical Biology 2015, 28:91–98
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(GBL)-based circuits as complementary, orthogonal tools.
We briefly introduce the GBL signalling system from
Streptomyces and evaluate recent progress in the charac-
terization of this cell-to-cell communication mechanism
and its application as an engineering tool. Finally, we
conclude by suggesting future applications of GBL cir-
cuits as synthetic biology tools.
The GBL signalling circuits
The soil-dwelling Streptomyces species are abundant
sources of antibiotics and other secondary metabolites
of medical interest [21]. In Streptomyces species, cell-to-
cell communication is a critical factor to coordinate the
onset of antibiotic production and/or morphological dif-
ferentiation, and the end product might be toxic even to
the producing strain [22]. Inter-cellular coordination is
achieved via bacterial hormones, in a manner analogous to
AHL-based quorum sensing. In the case of Streptomyces,
the signalling compounds are GBL. Currently, at least
fifteen different GBLs have been identified in different
Streptomyces species [22,23]. They share a common lac-
tone ring of 3R-hydroxymethyl-1,4-butyrolactone and a
C2 n-alkane residue, which is specific for each species and
has a unique stereochemistry, chain length or branching
[22].
GBLs promote a growth phase-dependent switch-like
transition to antibiotic production by binding to a recep-
tor protein, a homodimer from the TetR family of repres-
sors. Recognition of the signalling molecule occurs
through the C-terminal region of the protein [24]. A
recent publication [25] has shown that the GBL core
directly interacts with the binding pocket of the receptor,
implying that this structure is responsible for the recog-
nition of the GBL, whereas the n-alkane C2 residue may
be responsible for the specificity of the binding, and
therefore the threshold concentration necessary to per-
form the switch-like transition, as previously suggested
by Hsiao et al. [26].
In the general scenario (Figure 1a), the receptor protein
regulates its own transcription and that of a synthase
protein, which is supposed to catalyse the condensation
of dihydroxyacetone phosphate with a beta-ketoacid to
produce GBLs [22,27]. However, how this regulation
affects the GBL production or the switch-like transition
to antibiotic-producing strain is still the target of active
research, due to the diverse genetic topology of the
circuits found in different Streptomyces species
(Figure 1b–e) [28–31].
In S. griseus, the synthase protein, which catalyses bio-
synthesis of the GBL autoregulatory factor (A-factor), is
encoded approximately 100 kbp upstream from the GBL
receptor protein, which negatively represses transcription
of the master regulator AdpA, a positive regulator ofCurrent Opinion in Chemical Biology 2015, 28:91–98 morphological differentiation and antibiotic (streptomy-
cin and other) production and negative regulator of its
own transcription [28,32] (Figure 1b). A functional AdpA
homologue is also found in other Streptomyces species,
such as in Streptomyces coelicolor, where it was recently
shown that, in contrast to what has been reported for S.
griseus, the AdpA acts as a positive self-regulator [33].
However, in S. coelicolor antibiotic production is not
regulated by A-factor GBL, but by the GBLs SCB1–3
[26,29] (Figure 1c). Their synthesis involves the ScbA
protein, whose gene is encoded divergently from the
GBL receptor, ScbR. Moreover, the promoter regions
of receptor and synthase gene show a unique overlap
of 53 bp. It has been suggested that this overlapping
topology is responsible for the precise transition of the
regulatory system at relatively low GBL concentration
[34]. Similar divergent patterns of receptor and synthase
genes have been found in other Streptomyces species
(Table 1), although overlapping promoters seem to be
unique to S. coelicolor.
New building parts for GBL circuit engineering
A large diversity of GBL receptor proteins and regulatory
circuits is known, and even more have been discovered in
the last two years. For example, Zou and colleagues
identified and characterized the GBL receptor in Strepto-
myces venezuelae, JadR3, whose cognate GBL is SVB1
[35]. This protein acts as a positive regulator of jado-
mycin production by negatively controlling GBL produc-
tion by repressing transcription of the GBL synthase
jadW, and positively controlling the transcription of the
jadomycin cluster activator protein, JadR1, resulting in
interlinked feedback loops. The same circuit motif, with
one receptor protein acting as both a repressor and an
activator, has previously been suggested for other recep-
tors, such as ScbR from S. coelicolor [29], FarA from
Streptomyces lavendulae [36] (Figure 1d). Interestingly,
the new data of Zou et al. show that the GBL SVB1 from
S. venezuelae is identical to the GBL SCB3 from S.
coelicolor. This is the first example of two Streptomyces
species sharing a native autoregulatory signal. Earlier,
Recio and coworkers [37] had already demonstrated that
addition of exogenous A-factor from S. griseus to Strepto-
myces natalensis enhanced primaricin production in the
latter. These findings suggest that GBLs may be involved
in interspecies communication [38], a mechanism that
could be exploited in synthetic biology applications.
In Streptomyces avermitilis, Wang et al. identified and
characterized the GBL receptor AvaR1 [39]. This protein
indirectly regulates the production of the antiparasitic
avermectin by repressing transcription of the master
regulator of avermectin production, the aco gene. Com-
pound production is activated upon binding with its
cognate GBL, avenolide. Also, in Streptomyces tsukubaensis,
a GBL receptor, BulR1, was identified, in addition to a
pseudo-receptor homologue, BulR2 [40]. The BulR1www.sciencedirect.com
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Schematic sketch of the core GBL signalling circuitry (a) and four examples of proposed regulatory topologies suggested for different
Streptomyces species (b–e). Not all the details of the individual circuits have been experimentally validated, and hypothetical connections are
indicated as dashed lines. The direction of the regulatory influences is shown by arrowheads (positive regulation), bars (negative regulation) or
question marks (unknown direction of regulation). Orange lines (for example, interaction 1 in panel (a)) indicate the negative effect of GBL binding
on the ability of the receptor to bind to DNA. Red lines indicate an effect of the GBL receptor, and blue lines an effect of the synthase. Panel (a):
A, GBL synthase; R, GBL receptor. (b) In S. griseus, the autoregulatory factor (A-factor) synthase and receptor do not regulate each other’s
expression. A-factor binds the ArpA repressor; releasing it from the promoter region of the pleiotropic regulator adpA, a master regulator for
morphological differentiation and secondary metabolite production. A-factor-dependent derepression of adpA results in production of streptomycin
and other polyketides [33]. (c) In S. coelicolor, the receptor protein ScbR is transcribed in the opposite direction from the adjacent g-butyrolactone
synthase, scbA, and their promoter regions overlap 53 bp. It has been suggested that this topology contributes to the ability of generating a
precise on/off transition of the regulatory system at relatively low concentrations of g-butyrolactone [34]. The yellow star in the promoter region
indicates this putative effect of transcriptional interference due to promoter overlap. (d) In S. lavendulae, the synthase gene farX is encoded
upstream of the receptor gene farA, which, when not bound to butyrolactone, positively regulates the synthase transcription [36]. (e) In S. virginiae,
the receptor protein BarA is transcribed in the opposite direction from the adjacent g-butyrolactone synthase, BarX, and the unliganded form of
BarA positively effects the transcription of barX [60]. Additionally, the pseudo-repressor BarB delays streptogramin production until the strain has
acquired the necessary resistance to the producing biological agents [43]. Green lines (interaction 2) indicate the fast negative feedback loop
suppressing antibiotic synthesis until antibiotic resistance has been established.receptor acts as a positive regulator of the biosynthesis of
the immunosuppressant tacrolimus, an important human
drug. Despite this important finding, the cognate GBL
has still not been identified.
The crystal structure of CprB, a GBL pseudo-receptor
homologue bound to DNA has been elucidated recently
[24]. Together with the earlier crystal structure of thewww.sciencedirect.com apo form of the receptor [41] this creates an exciting
opportunity to understand the molecular mechanisms of
the receptor–GBL complex. Many groups have so far
tried unsuccessfully to crystallize GBL receptors, but
these resolved structures of closely related pseudo-recep-
tors should stimulate further crystallization attempts,
providing the necessary knowledge to engineer cus-
tom-made GBL receptors of optimized affinity.Current Opinion in Chemical Biology 2015, 28:91–98
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Table 1
Examples of GBL signalling systems in different Streptomyces species. The gene orientation is determined as the orientation of the
synthase relative to the receptor and has been labelled as divergent, if they are encoded in different DNA strands, and consecutive, if they
are encoded in the same DNA strand. The distance given, when known, is the minimum base pairs between both coding sequences
Strain GBL receptor GBL synthase Relative orientation, distance GBL(s) Refs
S. acidiscabies SabR SabA Divergent, 88 bp Unknown [50]
S. ambofaciens AlpZ AlpA Consecutive, Different subclusters Unknown [51]
S. aureofaciens SagR SagA Consecutive, 1 kb Unknown [45]
S. avermitilis AvaR1 aco Divergent, 445 bp Avenolide [23]
S. chattanoogensis ScgR ScgA/ScgX Divergent, 179 bp Unknown [48]
S. coelicolor ScbR ScbA Divergent, 117 bp SCB1-3 [29]
S. griseus ArpA Afsa Consecutive, 100 kb A-factor [28,53]
S. hygroscopicus ShbR3 ShbA3 Divergent, unknown Unknown [54]
S. lavendulae FarA FarX Consecutive, 189 bp IM-2 [21]
S. natalensis SngR SngA Divergent, 159 bp Unknown [55,56]
S. pristinaespiralis SpbR Unknown Unknown [57]
S. rochei (plasmid pSLA2-L) SrrA SrrX Divergent, 2.5 kb Unknown [58,59]
S. venezuelae JadR3 JadW Divergent, unknown SVB1 [35]
S. virginiae BarA BarX Divergent, 259 bp VB A-E [27,60]In another exciting recent development, it has become
more and more apparent that, in addition to the core
receptor–synthase circuit, Streptomyces species contain a
diverse range of auxiliary proteins that modulate antibi-
otic production by fine-tuning the response of the circuit;
e.g., in S. lavendulae FRI-5, recent evidence suggests that
the virginiamycin M and virginiamycin S antibiotic-spe-
cific Streptomyces antibiotic regulatory protein (SARP)
FarR4 negatively affects the production of the GBL
IM-2[36]. Intriguingly, in S. virginiae, a secondary repres-
sor, BarB, represses transcription of the SARP gene vmsR,
a pleiotropic inducer of virginiamycin M and virginiami-
cyn S production, until the strain has acquired resistance
to these antibiotics [42] (Figure 1e). BarB belongs to a
family of proteins known as pseudo-receptors, homolo-
gues of GBL receptor proteins without the ability to bind
the GBL ligand. Similar arrangements using the GBL
system in Streptomyces pristinaespiralis, which produces
pristinamycin, an analogue of virginiamycin, has also
been shown [43]. Pseudo-receptors like this seem to be
widespread, and while the function of most of these
remains unknown, recent controversial findings suggest
that some of them may be involved in interspecies
communication based on antibiotics recognition [38,
44] or in the regulation of GBL production [45]. More
research in this area could provide an additional layer
of regulatory tools to assemble circuits with a broad range
of different stimulus–response curves based on the same
core GBL design.
Novel applications of GBL circuits
The advantages of GBL-based signalling circuits were
first realized about a decade ago, when Weber and co-
workers [46] used GBL receptors to construct synthetic
devices in mammalian cells. By fusing the ScbR to the
eukaryotic transactivator domain (VP16), they created a
non-toxic way to control transcription in mammalian cells.Current Opinion in Chemical Biology 2015, 28:91–98 The level of complexity of the resulting circuit has now
been taken to a new level by Folcher et al. [47], creating
synthetic bipartite or even tripartite transcriptional factors
by fusing ScbR with TetR and/or TtgR prokaryotic
repressor proteins. Their proposed system allows fine-
tuning of induction or repression of different transgenes
with only two (or three) different molecules, in a way
analogous to electronic double-pole double throw
(DPDT) relay switches. In their paper, Folcher et al.
argue that genetic DPDT switches might in the future
be used to fine–tune a transition between two distinct
metabolic network states.
Moreover, Stanton et al. [48] performed a characteriza-
tion of different TetR-like proteins (including ScbR) and
used these to construct synthetic logic gates. Results from
this work suggest that the use of TetR-like proteins
provides accurate synchronous responses and facilitates
the design of synthetic genetic logic gates.
In addition to a general expansion of the synthetic biology
toolbox, GBL-based circuits promise two major advan-
tages for future applications as sensitive orthogonal ex-
pression regulatory systems and for the synchronization
of engineered strains.
First, at least fifteen different GBLs have been charac-
terized, each with specific and highly sensitive receptors,
which might provide alternative design options to over-
come the limitations imposed by the promiscuity seen in
the AHL-based systems. It is unclear whether the spe-
cies-specific systems are fully orthogonal or not, due to
firstly the uncertain origin of the beta-ketoacid required
for the initial biosynthetic step, secondly the catalytic
mechanism of the central enzyme of the circuit; and
finally the possibility of cross-talk at very high concen-
trations of GBL due to recognition of the commonwww.sciencedirect.com
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Schematic representation of future synthetic biology applications enabled by the diversity of natural GBL circuitry. (a) Potentially, two orthogonal
GBL-based switches with different threshold could operate in parallel to achieve a two-stage transition. This could be applied for the staged
activation of biosynthetic pathways or in sequential cellular decision making. (b) Multiple GBL receptors with independent signal specificity could
operate in one strain (integrating strain) to allow responses to multiple parallel inputs. This could be used, for example, to implement logic circuits
that integrate input signals from different GBL-producing strains.g-butyrolactone ring. Nonetheless, one can envisage
interleaved designs in which two GBL-based systems
are combined in an integrated circuit to implement a
multi-state system with, for example, two sequential
switch-like transitions at different thresholds by altering
the GBL-receptor binding specificity of one or both of
the receptors (Figure 2a). Multi-state systems could be
used to program sequential behaviours in which an
engineered strain would undergo a first switch-like tran-
sition to a stable state (out1), and after a programmed
time the same strain would undergo a second switch-like
transition to a stable state (out2) or to the OFF state
again.
Moreover, when using exogenous signals to control or-
thogonal expression induction systems, different GBLs
can be used as parallel input channels, upstream of
synthetic logic circuits (Figure 2b). This would provide
a system that would allow complex control strategies, for
example to tightly regulate the expression profile of
programmed metabolic pathways, as the system could
undergo a predefined number (n in Figure 2b) of bistablewww.sciencedirect.com transitions depending on the sequence of GBLs added to
the culture. This technology could be used to implement
multicellular decision making, where one system respon-
sive to multiple inputs integrates information from dif-
ferent GBLs by producing distributed sensor modules in
other cells. This would become a major advantage in the
design of cell computation devices, as currently even the
design of a four input-based AND gate is a laborious and
complex task using the available limited set of AHL-
based systems [49].
Future perspectives
Even if the core mechanism of the GBL circuitry is
sufficiently well understood to attempt its exploitation
in synthetic biology, more research needs to be performed
to realize its full potential. It would be highly desirable to
better understand how the genetic architecture influences
(and potentially fine-tunes) the transition behaviour. A
critical experiment will be to compare the behaviour of
the wild-type genetic architecture (preferentially in a
heterologous host) to a library of refactored variants
testing different degrees of transcriptional and translationalCurrent Opinion in Chemical Biology 2015, 28:91–98
96 Synthetic biology(un)coupling. Even the basic test of transplanting the core
circuit (receptor–promoter–synthase) to an environment
other than its native host has not been performed yet, and
the results of such an experiment will be of greatest
interest.
Another area for future experimental exploration is the
characterization of the commonly observed ‘pseudo-
receptors’ as putative modulators of the GBL response
curve. Determining the binding sites of these putative
regulatory proteins on a genome-wide scale should help
elucidating the biological function of these proteins.
Finally, further crystallization and structural determina-
tion of additional instances of the main components of the
GBL system (receptors, auxiliary proteins and synthases)
will expand our ability to engineer circuit variants with
bespoke sensitivity and response characteristics.
Although the use of GBL circuits as additions to the
synthetic biology toolbox is only just beginning, their
unique features suggest that they will be valuable tools to
complement AHL-based systems for the design of in-
creasingly complex cellular circuits for a wide range of
applications.
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